Get the App
A

Avrobio (AVRO)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Avrobio (AVRO)

AVROBIO, Inc. is a clinical-stage gene therapy company. The Company is focused on developing curative ex vivo lentiviral-based gene therapies to treat patients with rare diseases following a single dose treatment regimen. Its gene therapies employ he... Read more

  • USD1.05
  • USD1.08
  • USD0.94
  • USD1.93
  • -29.30%
  • --
  • 489.99k
  • 530.88k
  • 43M
  • 0.56
  • -38.30%

Stock News

EDP Renewables Places Multi-Year Order for 1.8 GW of First Solar Modules

22 minutes ago

EDP Renewables Places Multi-Year Order for 1.8 GW of First Solar Modules

Yahoo

Tenaris to Increase its Participation in Usiminas Control Group

1 hour ago

Tenaris to Increase its Participation in Usiminas Control Group

Yahoo

Binance hid links to China

1 hour ago

Binance hid links to China

Yahoo

The Margin: 40% of Americans are still earning less than 1% on their savings accounts — yet some banks are offering more than 4%

2 hours ago

The Margin: 40% of Americans are still earning less than 1% on their savings accounts — yet some banks are offering more than 4%

MarketWatch

More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.

Try Premium